Published in BMC Med Genet on May 20, 2013
Association between serum free fatty acid levels and nonalcoholic fatty liver disease: a cross-sectional study. Sci Rep (2014) 0.98
Human Genetic Ancestral Composition Correlates with the Origin of Mycobacterium leprae Strains in a Leprosy Endemic Population. PLoS Negl Trop Dis (2015) 0.76
Association of MTTP gene variants with pediatric NAFLD: A candidate-gene-based analysis of single nucleotide variations in obese children. PLoS One (2017) 0.75
Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications. Hepatology (2010) 5.35
Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered mice. J Clin Invest (2008) 5.27
Asians have lower body mass index (BMI) but higher percent body fat than do whites: comparisons of anthropometric measurements. Am J Clin Nutr (1994) 3.78
Insulin resistance: a metabolic pathway to chronic liver disease. Hepatology (2005) 3.44
Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis: the central role of nontriglyceride fatty acid metabolites. Hepatology (2010) 3.11
Epigenetics: a molecular link between environmental factors and type 2 diabetes. Diabetes (2009) 2.96
Epidemiology of non-alcoholic fatty liver disease in China. J Hepatol (2008) 2.72
Lipolysis and lipid mobilization in human adipose tissue. Prog Lipid Res (2009) 2.57
What are the risk factors and settings for non-alcoholic fatty liver disease in Asia-Pacific? J Gastroenterol Hepatol (2007) 2.54
The link between abdominal obesity, metabolic syndrome and cardiovascular disease. Nutr Metab Cardiovasc Dis (2006) 2.47
Signalling mechanisms regulating lipolysis. Cell Signal (2005) 2.32
From the metabolic syndrome to NAFLD or vice versa? Dig Liver Dis (2010) 2.24
Regulation of triglyceride metabolism. IV. Hormonal regulation of lipolysis in adipose tissue. Am J Physiol Gastrointest Liver Physiol (2007) 1.97
Hepatic steatosis: a role for de novo lipogenesis and the transcription factor SREBP-1c. Diabetes Obes Metab (2010) 1.96
Hepatic overexpression of hormone-sensitive lipase and adipose triglyceride lipase promotes fatty acid oxidation, stimulates direct release of free fatty acids, and ameliorates steatosis. J Biol Chem (2008) 1.94
Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes. Gastroenterology (2008) 1.78
Lipid and lipoprotein dysregulation in insulin resistant states. Clin Chim Acta (2006) 1.73
Effect of liver fat on insulin clearance. Am J Physiol Endocrinol Metab (2007) 1.64
Importance of changes in adipose tissue insulin resistance to histological response during thiazolidinedione treatment of patients with nonalcoholic steatohepatitis. Hepatology (2009) 1.59
Hepatic steatosis rather than visceral adiposity is more closely associated with insulin resistance in the early stage of obesity. Metabolism (2008) 1.56
Adipose triglyceride lipase and hormone-sensitive lipase protein expression is decreased in the obese insulin-resistant state. J Clin Endocrinol Metab (2007) 1.54
The developmental origins, mechanisms, and implications of metabolic syndrome. J Nutr (2010) 1.41
Significant correlations between severe fatty liver and risk factors for metabolic syndrome. J Gastroenterol Hepatol (2007) 1.36
A fresh look at NASH pathogenesis. Part 1: the metabolic movers. J Gastroenterol Hepatol (2010) 1.23
The inflamed liver and atherosclerosis: a link between histologic severity of nonalcoholic fatty liver disease and increased cardiovascular risk. Dig Dis Sci (2009) 1.19
Expression of fatty acid synthase in nonalcoholic fatty liver disease. Int J Clin Exp Pathol (2010) 1.18
Fatty acids and insulin resistance in muscle and liver. Best Pract Res Clin Endocrinol Metab (2005) 1.08
Extracellular fatty acid synthase: a possible surrogate biomarker of insulin resistance. Diabetes (2010) 1.02
Visceral obesity and metabolic syndrome: two faces of the same medal? Intern Emerg Med (2009) 0.94
Body fat distribution, adipocyte size, and metabolic characteristics of nondiabetic adults. J Clin Endocrinol Metab (2009) 0.93
Impact of visceral adipose tissue on liver metabolism and insulin resistance. Part II: Visceral adipose tissue production and liver metabolism. Diabetes Metab (2008) 0.84
Genetic variation at the hormone sensitive lipase: gender-specific association with plasma lipid and glucose concentrations. Clin Genet (2004) 0.83
Val1483Ile in FASN gene is linked to central obesity and insulin sensitivity in adult white men. Obesity (Silver Spring) (2009) 0.83
Variation in the promoter of the human hormone sensitive lipase gene shows gender specific effects on insulin and lipid levels: results from the Ely study. Biochim Biophys Acta (2001) 0.83
Association of the hormone sensitive lipase -60C > G variant with fasting insulin levels in healthy young men. Nutr Metab Cardiovasc Dis (2002) 0.82
Identification of genetic variation in the human hormone-sensitive lipase gene and 5' sequences: homology of 5' sequences with mouse promoter and identification of potential regulatory elements. Biochem Biophys Res Commun (1998) 0.81
The hormone-sensitive lipase C-60G promoter polymorphism is associated with increased waist circumference in normal-weight subjects. Int J Obes (Lond) (2006) 0.80
LIPE C-60G influences the effects of physical activity on body fat and plasma lipid concentrations: the Quebec Family Study. Hum Genomics (2009) 0.80
Cloning and functional characterization of the 5' regulatory region of ovine Hormone Sensitive Lipase (HSL) gene. Gene (2008) 0.78
Pegylated interferon-α2a with or without low-dose ribavirin for treatment-naive patients with hepatitis C virus genotype 1 receiving hemodialysis: a randomized trial. Ann Intern Med (2013) 2.84
The impact of prophylactic antibiotics on postoperative infection complication in elective laparoscopic cholecystectomy: a prospective randomized study. Am J Surg (2006) 2.41
Associations between hepatitis C viremia and low serum triglyceride and cholesterol levels: a community-based study. J Hepatol (2008) 1.82
Role of interleukin-28B polymorphisms in the treatment of hepatitis C virus genotype 2 infection in Asian patients. Hepatology (2011) 1.68
Rapid virological response and treatment duration for chronic hepatitis C genotype 1 patients: a randomized trial. Hepatology (2008) 1.64
A randomised study of peginterferon and ribavirin for 16 versus 24 weeks in patients with genotype 2 chronic hepatitis C. Gut (2006) 1.59
Early identification of achieving a sustained virological response in chronic hepatitis C patients without a rapid virological response. J Gastroenterol Hepatol (2010) 1.54
Profound week 4 interferon responsiveness is mandatory for hepatitis C genotype 1 patients with unfavorable IL-28B genotype. J Clin Virol (2013) 1.45
Significant correlations between severe fatty liver and risk factors for metabolic syndrome. J Gastroenterol Hepatol (2007) 1.36
Efficacy and safety of pegylated interferon combined with ribavirin for the treatment of older patients with chronic hepatitis C. J Infect Dis (2010) 1.34
The PNPLA3 I148M polymorphism is associated with insulin resistance and nonalcoholic fatty liver disease in a normoglycaemic population. Liver Int (2011) 1.33
CT evaluation of gastrointestinal tract perforation. Clin Imaging (2004) 1.27
Interleukin-28B genetic variants in identification of hepatitis C virus genotype 1 patients responding to 24 weeks peginterferon/ribavirin. J Hepatol (2011) 1.18
Risk factors for wound infection after cholecystectomy. J Formos Med Assoc (2004) 1.16
Insulin resistance predicts response to peginterferon-alpha/ribavirin combination therapy in chronic hepatitis C patients. J Hepatol (2009) 1.13
The role of gender on clearance of hepatitis C virus: a different story in an area endemic for hepatitis B and C. Gut (2007) 1.10
Hypertriglyceridemia-associated acute pancreatitis with chylous ascites in pregnancy. J Formos Med Assoc (2006) 1.09
Bacteriology and antimicrobial susceptibility in biliary tract disease: an audit of 10-year's experience. Kaohsiung J Med Sci (2002) 1.09
Tumor necrosis factor- alpha promoter polymorphism at position -308 predicts response to combination therapy in hepatitis C virus infection. J Infect Dis (2005) 1.09
The incidence and risks of liver biopsy in non-cirrhotic patients: An evaluation of 3806 biopsies. Gut (2007) 1.08
Intestinal parasitic infection detected by stool examination in foreign laborers in Kaohsiung. Kaohsiung J Med Sci (2010) 1.06
Viral hepatitis infections in southern Taiwan: a multicenter community-based study. Kaohsiung J Med Sci (2010) 1.02
Host interleukin-28B genetic variants versus viral kinetics in determining responses to standard-of-care for Asians with hepatitis C genotype 1. Antiviral Res (2011) 1.00
Hepatitis C virus viremia and low platelet count: a study in a hepatitis B & C endemic area in Taiwan. J Hepatol (2009) 0.98
Imaging of transmural migration of a retained surgical sponge: a case report. Kaohsiung J Med Sci (2004) 0.98
Stem cell marker nestin is critical for TGF-β1-mediated tumor progression in pancreatic cancer. Mol Cancer Res (2013) 0.97
Selenium, iron, copper, and zinc levels and copper-to-zinc ratios in serum of patients at different stages of viral hepatic diseases. Biol Trace Elem Res (2006) 0.96
Spontaneous retroperitoneal biloma: a case report. Kaohsiung J Med Sci (2002) 0.95
The incidence of oropharyngeal cancer in Taiwan: an endemic betel quid chewing area. J Oral Pathol Med (2002) 0.94
Chronic hepatitis C infection is associated with insulin resistance and lipid profiles. J Gastroenterol Hepatol (2015) 0.92
The activation of MEK/ERK signaling pathway by bone morphogenetic protein 4 to increase hepatocellular carcinoma cell proliferation and migration. Mol Cancer Res (2012) 0.92
HBsAg profiles in patients receiving peginterferon alfa-2a plus ribavirin for the treatment of dual chronic infection with hepatitis B and C viruses. J Infect Dis (2010) 0.90
Natural course of splenic artery aneurysm with associated spontaneous splenorenal shunt in non-cirrhotic liver: an 18-year observational follow-up and review of literature. Kaohsiung J Med Sci (2012) 0.89
Hepatic steatosis and fibrosis in chronic hepatitis C in Taiwan. Jpn J Infect Dis (2007) 0.89
[Relationships between emotional distress, empowerment perception and self-care behavior and quality of life in patients with type 2 diabetes]. Hu Li Za Zhi (2010) 0.89
Serum hs-CRP was correlated with treatment response to pegylated interferon and ribavirin combination therapy in chronic hepatitis C patients. Hepatol Int (2010) 0.87
Outcome of chronic hepatitis C patients who required early termination of pegylated interferon-alpha plus ribavirin combination therapy. Antivir Ther (2006) 0.87
Cirrhosis as a risk factor for tuberculosis infection--a nationwide longitudinal study in Taiwan. Am J Epidemiol (2014) 0.87
SMAD4 loss triggers the phenotypic changes of pancreatic ductal adenocarcinoma cells. BMC Cancer (2014) 0.86
Benzyl butyl phthalate induces migration, invasion, and angiogenesis of Huh7 hepatocellular carcinoma cells through nongenomic AhR/G-protein signaling. BMC Cancer (2014) 0.86
Pioglitazone retrieves hepatic antioxidant DNA repair in a mice model of high fat diet. BMC Mol Biol (2008) 0.86
Revisiting the stopping rule for hepatitis C genotype 1 patients treated with peginterferon plus ribavirin. PLoS One (2012) 0.86
Adefovir dipivoxil treatment of lamivudine-resistant chronic hepatitis B. Antiviral Res (2007) 0.85
Lifestyle and psychosocial factors associated with chronic periodontitis in Taiwanese adults. J Periodontol (2003) 0.85
Survival comparison between surgical resection and percutaneous radiofrequency ablation for patients in Barcelona Clinic Liver Cancer early stage hepatocellular carcinoma. Indian J Gastroenterol (2012) 0.85
The impact of body mass index on laparoscopic cholecystectomy in Taiwan: an oriental experience. J Hepatobiliary Pancreat Surg (2009) 0.85
Huge gap between clinical efficacy and community effectiveness in the treatment of chronic hepatitis C: a nationwide survey in Taiwan. Medicine (Baltimore) (2015) 0.84
HBV infection in indigenous children, 20 years after immunization in Taiwan: a community-based study. Prev Med (2009) 0.83
Clinical utility of host genetic IL-28B variants in hepatitis C virus genotype 1 Asian patients retreated with pegylated interferon plus ribavirin. J Gastroenterol Hepatol (2013) 0.83
Consolidation therapy for HBeAg-positive Asian chronic hepatitis B patients receiving lamivudine treatment: a multicentre study. J Antimicrob Chemother (2013) 0.83
Acute brachial artery thrombosis: a rare complication of diabetic ketoacidosis. Kaohsiung J Med Sci (2006) 0.83
Increased unbound retinol-binding protein 4 concentration induces apoptosis through receptor-mediated signaling. J Biol Chem (2012) 0.83
Association between transforming growth factor-beta 1 polymorphism and virologic characteristics of chronic hepatitis C. Transl Res (2008) 0.82
A case of acromegaly complicated with diabetic ketoacidosis, pituitary apoplexy, and lymphoma. Kaohsiung J Med Sci (2013) 0.82
Long-term effects of interferon-based therapy for chronic hepatitis C. Oncology (2007) 0.82
Comparison of adverse effects related to pegylated interferon-based therapy for patients with chronic hepatitis B and chronic hepatitis C in Taiwan. Hepatol Int (2010) 0.82
Treatment efficacy of pegylated interferon plus ribavirin therapy in chronic hepatitis C patients with mixed genotype 1/2 infection. J Gastroenterol Hepatol (2014) 0.82
Performance characteristics of two real-time PCR assays for quantification of hepatitis B virus DNA. Scand J Infect Dis (2009) 0.82
Performance characteristics of a combined hepatitis C virus core antigen and anti-hepatitis C virus antibody test in different patient groups. Kaohsiung J Med Sci (2011) 0.82
Virological predictors of response to retreatment in hepatitis C genotype 2 infected patients. PLoS One (2013) 0.82
Pretreatment glucose status determines HCC development in HCV patients with mild liver disease after curative antiviral therapy. Medicine (Baltimore) (2016) 0.81
SEN and hepatitis virus infections in nontransfused children and pediatric thalassemia patients with multiple transfusions in Taiwan. Digestion (2007) 0.81
Abnormal liver function test predicts type 2 diabetes: a community-based prospective study: response to Cho et al. Diabetes Care (2008) 0.81
Comparison of clinical application of the Abbott HBV PCR kit and the VERSANT HBV DNA 3.0 test to measure serum hepatitis B virus DNA in Taiwanese patients. Kaohsiung J Med Sci (2009) 0.81
Linkage of the hepatitis C virus genotype and interleukin-28B genetic polymorphisms in Asian patients. Hepatology (2011) 0.81
Significant association of ABCG8:D19H gene polymorphism with hypercholesterolemia and insulin resistance. J Hum Genet (2008) 0.81
Factors associated with quitting areca (betel) quid chewing. Community Dent Oral Epidemiol (2006) 0.80
Laparoscopic cholecystectomy in aged patients. Hepatogastroenterology (2009) 0.80
Hepatitis C virus infection among children in aboriginal areas in Taiwan. Trans R Soc Trop Med Hyg (2008) 0.80
Long-term effect of interferon plus ribavirin on hepatitis B surface antigen seroclearance in patients dually infected with hepatitis B and C viruses. PLoS One (2011) 0.79
Human leukocyte antigen alleles and the response to pegylated interferon/ribavirin therapy in chronic hepatitis C patients. Antiviral Res (2009) 0.79
Pancreatic Tumor Progression Associated With CD133 Overexpression: Involvement of Increased TERT Expression and Epidermal Growth Factor Receptor-Dependent Akt Activation. Pancreas (2016) 0.79
Outcome assessment in acute pancreatitis patients. Kaohsiung J Med Sci (2013) 0.79
A prospective study on treatment of chronic hepatitis C with tailored and extended interferon-alpha regimens according to pretreatment virological factors. Antiviral Res (2004) 0.79
Antinuclear antibody titer and treatment response to peginterferon plus ribavirin for chronic hepatitis C patients. Kaohsiung J Med Sci (2012) 0.78
Changing prevalence of hepatitis C virus infection among teenagers in an endemic area in Taiwan. Trans R Soc Trop Med Hyg (2008) 0.78
Mitochondrial polymorphism 12361A>G is associated with nonalcoholic fatty liver disease. Transl Res (2011) 0.78
Hepatitis B e antigen-negative patients with persistently normal alanine aminotransferase levels and hepatitis B virus DNA > 2000 IU/mL. Hepatology (2009) 0.78
Association of Brachial-Ankle Pulse Wave Velocity and Cardiomegaly With Aortic Arch Calcification in Patients on Hemodialysis. Medicine (Baltimore) (2016) 0.77
A novel mutation of transferrin receptor 2 in a Taiwanese woman with type 3 hemochromatosis. J Hepatol (2007) 0.77
Outcome of patients suffering from a spontaneous reactivation of hepatitis B presenting as acute-on-chronic liver failure and treated with antivirals. Hepatology (2011) 0.77
A 24-week course of high-dose interferon-alpha plus ribavirin for Taiwanese chronic hepatitis C patients with persistently normal or near-normal alanine aminotransferase levels. Liver Int (2006) 0.77
Aberrant p53 expression and the development of gallbladder carcinoma and adenoma. Kaohsiung J Med Sci (2006) 0.77
Early response to lamivudine therapy in clinically non-cirrhotic chronic hepatitis B patients with decompensation. Liver Int (2007) 0.77
Personalized Therapy of Chronic Hepatitis C and B Dually Infected Patients With Pegylated Interferon Plus Ribavirin: A Randomized Study. Medicine (Baltimore) (2015) 0.77
Interactions of a PPARGC1A Variant and a PNPLA3 Variant Affect Nonalcoholic Steatohepatitis in Severely Obese Taiwanese Patients. Medicine (Baltimore) (2016) 0.76
Association between gallbladder stones and chronic hepatitis C: ultrasonographic survey in a hepatitis C and B hyperendemic township in Taiwan. Kaohsiung J Med Sci (2013) 0.76
Hepatitis B virus genotyping by enzyme-linked immunosorbent assay in Taiwan. Hepatol Int (2010) 0.76
Rapid virological response to peginterferon and ribavirin for hepatitis C genotype 1: the role of weight-based ribavirin exposure. Hepatology (2008) 0.76
Rapid virological response in hepatitis C virus genotype 1 and early ribavirin exposure. Hepatology (2008) 0.75
High serum uric acid as a novel risk factor for type 2 diabetes: response to Dehghan et al. Diabetes Care (2008) 0.75
Unveiling glucose abnormalities in patients with chronic hepatitis C infection. Am J Gastroenterol (2009) 0.75
The substantial role of initial ribavirin dose on the response to peginterferon alpha/ribavirin therapy in patients with genotype 1b chronic hepatitis C. Am J Gastroenterol (2009) 0.75
Insurance status and treatment candidacy of patients with hepatitis C: Taiwanese patients are luckier. Hepatology (2011) 0.75
What can be revealed by extending the sensitivity of HBsAg detection to below the present limit? Beyond the applause for higher sensitivity. J Hepatol (2008) 0.75
Pretreatment prediction of virological response to peginterferon plus ribavirin therapy in patients with chronic hepatitis C, using viral and host factors: some concerns. Hepatology (2009) 0.75
A crossing in therapy for hepatitis C virus genotype 2 or 3: increasing ribavirin dose with shortened duration or reducing ribavirin dose with standard duration. Hepatology (2009) 0.75